
Connect Biopharma Holdings Limited
CNTBHealthcare|Biotechnology|US
$0.73
-0.00 (-0.41%)
DCF Value
$0.65
Tangible Book / Share
$0.43
Cash / Share
$0.50
Next Earnings Report
Nov 11, 2026
EPS est. -$0.27 · Revenue est. $114.8K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest May 15, 2026 (F-3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
Sep 30, 2026 · GlobeNewsWire
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation
Sep 15, 2026 · GlobeNewsWire
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 · GlobeNewsWire
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 12, 2026 · GlobeNewsWire
SEC Filings (50)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 6, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 30, 2026 | 8-K | Material event | DocumentIndex |
| Sep 15, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Jun 1, 2026 | EFFECT | DocumentIndex | |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | F-3 | Shelf registration | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| Apr 23, 2026 | 8-K | Material event | DocumentIndex |
| Apr 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 1, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 30, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Dec 23, 2025 | 8-K | Material event | DocumentIndex |
| Nov 28, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 26, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Sep 16, 2025 | 8-K | Material event | DocumentIndex |
| Sep 12, 2025 | EFFECT | DocumentIndex | |
| Sep 10, 2025 | POS AM | DocumentIndex | |
| Aug 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2025 | 8-K | Material event | DocumentIndex |
| Jul 22, 2025 | 8-K | Material event | DocumentIndex |
| Jul 21, 2025 | 8-K | Material event | DocumentIndex |
| Jul 21, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jul 18, 2025 | F-6 POS | DocumentIndex | |
| Jul 17, 2025 | 8-K | Material event | DocumentIndex |
| Jul 9, 2025 | 8-K | Material event | DocumentIndex |
| Jun 26, 2025 | EFFECT | DocumentIndex | |
| Jun 10, 2025 | S-8 | Employee stock plan | DocumentIndex |